Location History:
- Moscow, S (1976)
- Moscow, SU (1978 - 1986)
Company Filing History:
1 out of 1 
2 out of 832,812 Years Active: 1976-1986
Title: Innovator in Pharmaceuticals: Natalya Veniaminovna Kaverina
Introduction: Natalya Veniaminovna Kaverina is a distinguished inventor based in Moscow, Russia. With a significant contribution to the field of pharmaceuticals, she holds two patents that emphasize her innovative prowess in developing medicated compounds. Her work primarily addresses critical medical conditions, particularly ischemic heart disease.
Latest Patents: Kaverina's latest patents are groundbreaking in their applications for treating heart conditions. The first patent involves an antianginal medicated compound that incorporates the active principle 2,4,6,8-tetramethyl-2,4,6,8-tetraazobicyclo[3,3,0]octanedione-3,7. This compound, when combined with a pharmaceutical carrier, proves beneficial for treating patients suffering from ischemic heart disease. The second patent presents novel compounds of the phenothiazine family, specifically 10'-[ω-N/1,4-diazabicyclo(4,m,0)-alkanyl/acyl]-phenothiazines. These compounds are pharmacologically active and possess spasmolytic and coronary-dilatant effects, showcasing Kaverina's commitment to advancing therapeutic options in medicine.
Career Highlights: Natalya Kaverina has made her mark in the field of organic chemistry through her extensive work at the Institute of Organic Chemistry named after N.D. Zelinsky, part of the Academy of Sciences of the USSR. Her role there facilitated her pioneering research and patent developments, establishing her as a credible figure in pharmaceutical innovation.
Collaborations: Kaverina's innovative journey has also been enriched by her collaborations with esteemed colleagues, including Irina Evgenievna Zimakova and Dania A Valimukhametova. Their contributions have fostered a collaborative environment leading to significant advancements in their research endeavors.
Conclusion: As an inventor, Natalya Veniaminovna Kaverina represents the relentless pursuit of innovation in the pharmaceutical sector. Her patents reflect not only her expertise but also her dedication to enhancing healthcare through targeted and effective medication for serious health conditions. Her work continues to inspire upcoming generations of researchers and inventors.